Quretech Bio Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $25M

  • Investors
  • 11

Quretech Bio General Information

Description

Developer of antibacterial agents designed for combating infectious diseases and addressing antibiotic resistance. The company's platform focuses on creating a new class of small molecules with bactericidal effects on Gram-positive bacteria, including drug-resistant strains, featuring a novel mechanism of action, no cross-resistance, and activity against nondividing bacteria, enabling the healthcare market to access innovative methods for treating serious infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tvistevägen 48
  • 907 36 Umeå
  • Sweden
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Tvistevägen 48
  • 907 36 Umeå
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Quretech Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Grant 23-Dec-2025 $25M Completed Product Development
7. Later Stage VC 26-Oct-2020 Completed Product Development
6. Grant 21-Apr-2020 Completed Product Development
5. Grant 04-Dec-2019 Completed Product Development
4. Grant 21-Dec-2018 Completed Product Development
3. Later Stage VC 02-Oct-2018 Completed Product Development
2. Accelerator/Incubator 07-Apr-2016 $194K $194K Completed Product Development
1. Grant 01-Jan-2014 $5.04M Completed Product Development
To view Quretech Bio’s complete valuation and funding history, request access »

Quretech Bio Patents

Quretech Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022043537-A1 Thiazine compounds for use in the diagnosis, prevention and/or treatment of a disease and/or disorder involving amyloid Inactive 28-Aug-2020
EP-4146659-A1 Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria Active 08-May-2020
EP-4146659-B1 Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria Active 08-May-2020
ES-3017588-T3 Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria Active 08-May-2020
US-12503476-B2 Ring-fused 2-pyridone compounds, methods for preparation thereof and their use in the treatment and/or prevention of a disease involving gram-positive bacteria Active 08-May-2020 C07D513/04
To view Quretech Bio’s complete patent history, request access »

Quretech Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Quretech Bio Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Patent and Trademark Office Government
Nascent Invest Venture Capital Minority
The Kempe Foundations Limited Partner Minority
SWElife Government
Erling Persson Family Foundation Limited Partner
You’re viewing 5 of 11 investors. Get the full list »

Quretech Bio FAQs

  • When was Quretech Bio founded?

    Quretech Bio was founded in 2010.

  • Where is Quretech Bio headquartered?

    Quretech Bio is headquartered in Umeå, Sweden.

  • What is the size of Quretech Bio?

    Quretech Bio has 8 total employees.

  • What industry is Quretech Bio in?

    Quretech Bio’s primary industry is Drug Delivery.

  • Is Quretech Bio a private or public company?

    Quretech Bio is a Private company.

  • What is Quretech Bio’s current revenue?

    The current revenue for Quretech Bio is .

  • How much funding has Quretech Bio raised over time?

    Quretech Bio has raised $1.82M.

  • Who are Quretech Bio’s investors?

    United States Patent and Trademark Office, Nascent Invest, The Kempe Foundations, SWElife, and Erling Persson Family Foundation are 5 of 11 investors who have invested in Quretech Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process